肿瘤微环境
无容量
易普利姆玛
转移性黑色素瘤
彭布罗利珠单抗
肿瘤科
癌症免疫疗法
免疫学
作者
Claudia Ceci,Maria Grazia Atzori,Pedro Miguel Lacal,Grazia Graziani
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2020-11-17
卷期号:12 (11): 3401-
被引量:15
标识
DOI:10.3390/cancers12113401
摘要
Immune checkpoint inhibitors (ICIs) represent a promising therapeutic intervention for a variety of advanced/metastatic solid tumors, including melanoma, but in a large number of cases, patients fail to establish a sustained anti-tumor immunity and to achieve a long-lasting clinical benefit. Cells of the tumor micro-environment such as tumor-associated M2 macrophages (M2-TAMs) have been reported to limit the efficacy of immunotherapy, promoting tumor immune evasion and progression. Thus, strategies targeting M2-TAMs have been suggested to synergize with immune checkpoint blockade. This review recapitulates the molecular mechanisms by which M2-TAMs promote cancer immune evasion, with focus on the potential cross-talk between pharmacological interventions targeting M2-TAMs and ICIs for melanoma treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI